Approval · Notice of Compliance 10708 · 2009
SUMATRIPTAN: Notice of Compliance 10708
Issued October 21, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10708
- Date
- October 21, 2009
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Additional product name
- Therapeutic class
- 5-HT1 receptor agonist / Migraine therapy
- Canadian reference product
- IMITREX (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUMATRIPTAN | 02335093 | — |
| SUMATRIPTAN | 02335107 | — |
Medicinal ingredients
- SUMATRIPTAN SUCCINATE 50 MG per TAB
- SUMATRIPTAN SUCCINATE 100 MG per TAB